Literature DB >> 7201021

Self-administration of the endogenous trace amines beta-phenylethylamine, N-methyl phenylethylamine and phenylethanolamine in dogs.

H E Shannon, C M Degregorio.   

Abstract

beta-Phenylethylamine and phenylethanolamine are biogenic amines structurally related to amphetamine which are known to occur endogenously in trace amounts in mammalian brain. The purpose of the present experiments was to determine whether these endogenous biogenic amines, like amphetamine, have reinforcing properties. Dogs surgically prepared with i.v. catheters were permitted 4-hr daily access to i.v. infusions of beta-phenylethylamine, phenylethanolamine, N-methylphenylethylamine, cocaine or d-amphetamine under a fixed-ratio one-response schedule of reinforcement. In dogs which had not previously self-administered drugs, the number of infusions self-administered per session of beta-phenylethylamine, N-methyl phenylethylamine and cocaine increased above that for saline typically within 5 to 10 sessions. Increases in the number of injections per session were observed in only two of five dogs with phenylethanolamine, and in only three of five dogs with d-amphetamine within as many as 20 to 40 sessions. Does-effect curves were determined in dogs which had been trained previously to self-administer drug and whose daily drug intake was stable. The relative potencies of these compounds in maintaining self-administration behavior during the 4-hr session were d-amphetamine greater than cocaine greater than phenylethanolamine greater than or equal to N-methyl phenylethylamine greater than or equal to beta-phenylethylamine. These data indicate that the endogenous trace amines beta-phenylethylamine, phenylethanolamine and the N-methyl homolog of beta-phenylethylamine can function as reinforcers and are compatible with hypotheses that they may play a physiological role in the reinforcement process or in neuropsychiatric disorders.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7201021

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  7 in total

1.  Biphasic effects of selegiline on striatal dopamine: lack of effect on methamphetamine-induced dopamine depletion.

Authors:  K Grasing; R Azevedo; S Karuppan; S Ghosh
Journal:  Neurochem Res       Date:  2001-01       Impact factor: 3.996

2.  Differential aversive stimulus properties of beta-phenylethylamine and of d-amphetamine.

Authors:  A J Greenshaw; C T Dourish
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

3.  Reinforcing effects of phenethylamine analogs found in dietary supplements.

Authors:  Shelby A McGriff; Michael R Chojnacki; Eric B Thorndike; Kenner C Rice; Michael H Baumann; Charles W Schindler
Journal:  Psychopharmacology (Berl)       Date:  2022-10-03       Impact factor: 4.415

4.  Rat brain-uptake index for phenylethylamine and various monomethylated derivatives.

Authors:  Aron D Mosnaim; Owen H Callaghan; Thomas Hudzik; Marion E Wolf
Journal:  Neurochem Res       Date:  2013-02-07       Impact factor: 3.996

5.  The potentiation of cortical neuron responses to noradrenaline by 2-phenylethylamine is independent of endogenous noradrenaline.

Authors:  I A Paterson
Journal:  Neurochem Res       Date:  1993-12       Impact factor: 3.996

Review 6.  Trace amine-associated receptor 1-Family archetype or iconoclast?

Authors:  David K Grandy
Journal:  Pharmacol Ther       Date:  2007-07-17       Impact factor: 12.310

7.  Phentermine self-administration in naive free-feeding and food-deprived rats: a dose response study.

Authors:  M Papasava; G Singer; C L Papasava
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.